5-HT1A RECEPTOR ANTAGONISTS INCREASE THE ACTIVITY OF SEROTONERGIC CELLS IN THE DORSAL RAPHE NUCLEUS IN RATS TREATED ACUTELY OR CHRONICALLY WITH CITALOPRAM

• In this study we have examined the acute effects of systemic administration of the selective serotonin reuptake inhibitor (SSRI), citalopram, in combination with either of the two selective 5-HT1A receptor antagonists, (S)-5-fluoro-8-hydroxy-2-(dipropyla

Nyckelord

5-HT1A RECEPTOR ANTAGONIST; CITALOPRAM; ANTIDEPRESSANT; ELECTROPHYSIOLOGY; DORSAL RAPHE NUCLEUS; (S)-UH-301; (+)-WAY100135; POSTSYNAPTIC 5-HT(1A) RECEPTORS; FRONTAL-CORTEX; EXTRACELLULAR 5-HYDROXYTRYPTAMINE; REUPTAKE INHIBITOR; IN-VIVO; NEURONS; MICRODI

Publikations- och innehållstyp

vet (ämneskategori)

ovr (ämneskategori)